Nonoperative management protocol for locally advanced rectal cancer
Colorectal Disease · 2024
DOI: 10.1111/codi.17035 ↗At a glance
Studienprotokoll in Colorectal Disease, 2024. Written by Erin D Kennedy and 12 co-authors. Institution: Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada. Major MEDLINE topics: Chemoradiotherapy, Rectal Neoplasms. 23 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: CIHR, Canadian Institutes of Health Research.
Abstract (original language)
Aim
The standard treatment for low rectal cancer is preoperative chemoradiotherapy followed by surgery with low anterior resection with diverting ileostomy or abdominoperineal resection, both of which have significant long‐term effects on bowel and sexual function. Due to the high morbidity of surgery, there has been increasing interest in nonoperative management for low rectal cancer. The aim of this work is to conduct a pan‐Canadian Phase II trial assessing the safety of nonoperative management for low rectal cancer.
Method
Patients with Stage II or III low rectal cancer completing chemoradiotherapy according to standard of care at participating centres will be assessed for complete clinical response 8–14 weeks following completion of chemoradiotherapy. Subjects achieving a clinical complete response will undergo active surveillance including endoscopy, imaging and bloodwork at regular intervals for 24 months. The primary outcome will be the rate of local regrowth 2 years after chemoradiotherapy. Nonoperative management will be considered safe (i.e. as effective as surgery to achieve local control) if the rate of local regrowth is ≤30% and surgical salvage is possible for all local regrowths. Secondary outcomes will include disease‐free and overall survival.
Conclusion
The results will be highly clinically relevant, as it is expected that nonoperative management will be safe and lead to widespread adoption of nonoperative management in Canada. This change in practice has the potential to decrease the number of patients requiring surgery and the costs associated with surgery and long‐term surgical morbidity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Surgery, Mount Sinai Hospital, Toronto, Ontario, Canada.
- University of Toronto, Toronto, Ontario, Canada.
- Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Department of Colorectal Surgery, St Paul's Hospital, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Surgery, McGill University, Montréal, Quebec, Canada.
- Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.
ORCID profiles: Erin D Kennedy, Carl Brown
Funding
- CIHR
- Canadian Institutes of Health Research
Cite
APA
Kennedy, E. D., Schmocker, S., Brown, C., Liberman, S., Baxter, N. N., Drolet, S., Neumann, K., Simunovic, M., Richard, C., Brezden-Masley, C., Jhaveri, K., Kopek, N., & Kirsch, R. (2024). Nonoperative management protocol for locally advanced rectal cancer. Colorectal Disease. https://doi.org/10.1111/codi.17035
Vancouver
Kennedy ED, Schmocker S, Brown C, Liberman S, Baxter NN, Drolet S, et al. Nonoperative management protocol for locally advanced rectal cancer. Colorectal Disease. 2024. doi:10.1111/codi.17035
BibTeX
@article{Kennedy2024,
author = {Kennedy, Erin D and Schmocker, Selina and Brown, Carl and Liberman, Sender and Baxter, Nancy N and Drolet, Sebastien and Neumann, Katerina and Simunovic, Marko and Richard, Carole and Brezden-Masley, Christine and Jhaveri, Kartik and Kopek, Neil and Kirsch, Richard},
title = {Nonoperative management protocol for locally advanced rectal cancer},
journal = {Colorectal Disease},
year = {2024},
doi = {10.1111/codi.17035}
}
EUVIMED